Potential relationship between Helicobacter pylori and ischemic heart disease: Any pathogenic model?

Panminerva Medica

Volumn 50, Issue 2, 2008, Pages 161-163

  Berrutti, M ^a   Pellicano, R ^a,e   Fagoonee, S ^b   Astegiano, M ^a   Smedile, A ^a   Saracco, G ^a   Repici, A ^c   Leone, N ^d   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d GRADENIGO HOSPITAL   (Italy)

^e Department of Gastro Hepatology ^*  (Italy)

Author keywords

Helicobacter pylori; Myocardial infarction; Myocardial ischemia

Indexed keywords

ACUTE DISEASE; ANIMAL; DISEASE MODEL; HEART MUSCLE ISCHEMIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; SHORT SURVEY;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 52649148004     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (31)

1. Liu Y, Akiyama J, Graham DY. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol 2006;52:235-48.
2. Testino G. Gastric precancerous changes: carcinogenesis, clinical behaviour immunophenotype study and surveillance. Panminerva Med 2006;48:109-18.
3. Solnick JV, Francsechi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection-other Helicobacter species. Helicobacter 2006;11(Suppl.1):46-51.
4. Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol 2003;29:351-9.
5. Oliaro E, Fagoonee S, Pellicano R. On acute respiratory tract infections and acute myocardial infarction. New data confirm previous findings. Int Angiol 2007;26:391-2.
6. Pellicano R, Fagoonee S, Rizzetto M. On infections and ischemic heart diseases. Int Angiol 2007;26:390-1.
7. Pellicano R, Rizzetto M. Helicobacter pylori and coronary artery disease: which is the better target population? Dig Dis Sci 2007;52: 3041-2.
8. Pellicano R, Astegiano M, Rizzetto M. Helicobacter pylori and ischemic heart disease. Which potential pathogenic mechanisms? Saudi Med J 2006;27:427.
9. Pellicano R, Peyre S, Astegiano M, Oliaro E, Fagoonee S, Rizzetto M. Update review (2006) on Helicobacter pylori as a potentail target for the therapy of ischemic heart disease. Panminerva Med 2006;48:109-18.
10. Franceschi F, Leo D, Fini L, Santoliquido A, Flore R, Tondi P et al. Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig Liver Dis 2005;37:301-8.
11. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-2.
12. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-anlyses. BMJ 2000;321:199-204.
13. Manolakis A, Kapsoritakis AN, Potamianos SPA review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter 2007;12:287-97.
14. Adiloglu AK, Ocal A, Can R, Duver H, Yavuz T, Aridogan BC. Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation. Saudi Med J 2005;26:1068-74.
15. Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H, et al. Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 2002;34:398-402.
16. Di Bonaventura G, Piccolomini R, Pompilio A, Zappacosta R, Piccolomini M, Neri M. Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is there a relationship? Int J Immunopathol Pharmacol 2007;20:163-72.
17. Honda C, Adachi K, Arima N, Tanaka S, Yagi J, Morita T et al. Helicobacter pylori infection does not accelerate the age-related progression of arteriosclerosis: a 4-year follow-up study. J Gastroenterol Hepatol 2008 May 6 [Epub ahead of print].
18. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-2.
19. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-anlyses. BMJ 2000;321:199-204.
20. Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004;96:1470-6.
21. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003;124:1846-54.
22. Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Ramirez J et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997;100:996-1005.
23. Aguejouf O, Mayo K, Monteiro L, Doutremepuich F, Doutremepuich C, Mégraud F. Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice. Thrombosis Res 2003;108:245-8.
24. Kalia N, Bardhan KD, Reed MW, Jacob S, Brown NJ. Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo. Dig Dis Sci 2000;45:1343-51.
25. Consolazio A, Borgia MC, Ferro D, Iacopini F, Paoluzi OA, Crispino P et al. Increased thrombin generation and circulating levels of tumour necrosis factor-α in patients with chronic Helicobacter pylori -positive gastritis. Aliment Pharmacol Ther 2004;20:289-94.
26. Castelli R, Porro F, Savo D, Cassinerio E. New antithrombotic agents. Panminerva Med 2006;48:247-56.
27. Gràbczewska Z, Nartowicz E, Kubica J, RoÊç D. Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae. Eur J Int Med 2006; 17:339-42.
28. Grebowska A, Rechcinski T, Bak-Romaniszyn L, Czkwianianc E, Moran A, Druszczynska M et al. Potential role of LPS in the outcome of Helicobacter pylori related diseases. Pol J Microbiol 2006;55: 25-30.
29. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Gentiloni Silveri N, Gasbarrini G et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens. Possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002;106:430-4.
30. Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A et al. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter 2007; 12:298-305.
31. Fardi A, Papadimitriou D. Periodontal and atherosclerosis-induced diseases. Int Angiol 2007;26:197-205.